CBI Pharmaceutical Congress on Paragraph IV Disputes: Citizen Petitions and Their Impact on Generic Entry - PowerPoint PPT Presentation

1 / 22
} ?>
View by Category
About This Presentation
Title:

CBI Pharmaceutical Congress on Paragraph IV Disputes: Citizen Petitions and Their Impact on Generic Entry

Description:

Kurt R. Karst. Hyman, Phelps & McNamara, P.C. www.hpm.com. 202-737-7544. www.hpm.com krk_at_hpm.com ... FDA shall not delay approval of a pending ANDA or 505(b)(2) ... – PowerPoint PPT presentation

Number of Views:44
Avg rating:3.0/5.0
Slides: 23
Provided by: informat1418
Learn more at: http://www.fdalawblog.net
Category:

less

Write a Comment
User Comments (0)
About PowerShow.com